The CLL-specific CRC is centred on PAX5, a TF that promotes lymphomagenesis by activating signalling pathways indicated in B-cell signalling, and the knockdown of this gene results in dramatic effects on B-cell proliferation and development [41,83]. Here, TF is linked to colorectal carcinoma.